Early research (Phase 1)Study completedNCT03132792What this trial is testingAFPᶜ³³²T in Advanced HCCWho this might be right forHepatocellular CancerAFP Expressing Tumors Adaptimmune 39
Early research (Phase 1)Study completedNCT01625351What this trial is testingCD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasWho this might be right forEwing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more St. Jude Children's Research Hospital 23
Early research (Phase 1)Study completedNCT01129570What this trial is testingSiliphos in Advanced Hepatocellular CarcinomaWho this might be right forAdvanced Hepatocellular Carcinoma Abby Siegel 3
Testing effectiveness (Phase 2)Study completedNCT00076609What this trial is testingStudy of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaLiver Cancer PhytoCeutica 31
Early research (Phase 1)Looking for participantsNCT07391839What this trial is testingMDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.Who this might be right forHepatomaUnresectable Hepatocellular Carcinoma (HCC) Suzhou Mednovo Yi Medical Technology Co., Ltd. 40
Testing effectiveness (Phase 2)WithdrawnNCT04158700What this trial is testingLY3200882 and Pembrolizumab in Participants With Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company
Testing effectiveness (Phase 2)Active Not RecruitingNCT06239155What this trial is testingA Phase I/II Study of AST-3424 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsHepatocellular Carcinoma Ascentawits Pharmaceuticals, Ltd 51
Early research (Phase 1)Study completedNCT01008917What this trial is testingTemsirolimus and Sorafenib in Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma University of California, San Francisco 25
Testing effectiveness (Phase 2)Looking for participantsNCT06938880What this trial is testingStudy of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Suzhou Zelgen Biopharmaceuticals Co.,Ltd 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05194293What this trial is testingRegorafenib and Durvalumab for the Treatment of High-Risk Liver CancerWho this might be right forStage IB Hepatocellular Carcinoma AJCC v8Stage II Hepatocellular Carcinoma AJCC v8Stage III Hepatocellular Carcinoma AJCC v8+1 more Academic and Community Cancer Research United 4
Early research (Phase 1)Study completedNCT02210182What this trial is testingA Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Oncozyme Pharma Inc. 29
Early research (Phase 1)Looking for participantsNCT05488522What this trial is testingSBRT With Atezo/Bev for HCCWho this might be right forHepatocellular Carcinoma Abramson Cancer Center at Penn Medicine 18
Early research (Phase 1)Ended earlyNCT05093608What this trial is testingSELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Ended earlyNCT03480152What this trial is testingMessenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous CancerWho this might be right forMelanomaColon CancerGastrointestinal Cancer+2 more National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT02358395What this trial is testingBBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Sumitomo Pharma Co., Ltd. 12
Early research (Phase 1)Ended earlyNCT03998033What this trial is testingStudy of ET140202 T Cells in Adults With Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaLiver CancerLiver Neoplasm+1 more Eureka Therapeutics Inc. 2
Testing effectiveness (Phase 2)Looking for participantsNCT06811116What this trial is testingTesting the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE TrialWho this might be right forAdvanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+1 more National Cancer Institute (NCI) 92
Early research (Phase 1)Ended earlyNCT01668017What this trial is testingA Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as MonotherapyWho this might be right forAdvanced Solid TumorsHepatocellular Carcinoma Merck KGaA, Darmstadt, Germany 26
Testing effectiveness (Phase 2)Study completedNCT00987935What this trial is testingA Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma PatientsWho this might be right forCarcinoma, Hepatocellular Boehringer Ingelheim 134
Early research (Phase 1)Active Not RecruitingNCT02772003What this trial is testingDNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus InfectionWho this might be right forChronic HepatitisHepatitis C InfectionHepatocellular Carcinoma National Cancer Institute (NCI) 33